Allergy Relieving Eye Drops Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Allergy Relieving Eye Drops Market is Segmented by Drug Class (Antihistamines, Non-steroidal anti-Inflammatory Drugs, Vasoconstrictors, Others), Type, and Geography

Allergy Relieving Eye Drops Market Snapshot

Allergy Relieving Eye Drops Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.14 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The rise in prevalence and incidence rates of eye-related disorders, increased geriatric population, and increasing research and development in eye allergy medication are expected to boost the allergy-relieving eye drops market during the forecast period.

Eye Allergy has been increasing in recent years. According to a report by BioMed Research International 2017, the overall prevalence of ocular allergy among school children in Shanghai, China is about 28%. Also, it has been observed that around 15% to 20%of the US population suffers from an ocular allergy. This high prevalence of ocular allergy has increased the demand for allergy eye drops and hence, this factor has acted as a driving factor helping this market grow. However, side effects from allergy relieving eye drops, including irritation, headache, and others, have been restraining the overall growth of this market.

Scope of the Report

As per the scope of the report, an allergic reaction occurs when a person’s immune system reacts to an allergen in the environment, either indoors or outdoors. An allergen is any substance that causes allergy symptoms in sensitive individuals. Allergy relieving eye drops are thus used to prevent and treat itching of the eyes caused by allergies.

By Drug Class
Non-steroidal anti-Inflammatory Drugs
By Type
Seasonal and Perennial Allergic Conjunctivitis
Vernal Keratoconjunctivitis
Atopic Keratoconjunctivitis
Giant Papillary Conjunctivitis
North America
United States
United Kingdom
Rest of Europe
Asia Pacific
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Antihistamines are Expected to Register a High Growth Rate Over the Forecast Period

Antihistamines are found to block histamine release from histamine-1 receptors and are used to treat the symptoms of an allergic reaction such as edema (swelling), itch, inflammation (redness), and watery eyes. Eye edema is a very common occurrence that is primarily caused by unhealthy cornea prior to surgery. 

Subsequently, any procedure within the eye (such as cataract, glaucoma, or retinal surgery) can cause the cornea to fail and develop edema. Therefore antihistamines effectively treat edema and the market is expected to increase over the forecast period.

Allergy Relieving Eye Drops Market

North America is Expected to Dominate the Allergy Relieving Eye Drops Market

North America includes the United States (US), Canada, and Mexico. The United States and Canada have developed healthcare systems and also spend huge amounts in research and development fo the same. Therefore, as a result, most of the global treatments are available in this region.

According to a Yanqing Feng et al, published in BioMed Research International 2017, among the US households, 34% prevalence of Ocular Allergy symptoms were reported in children. This high prevalence has thus increased the demands for ocular allergy medications, which is helping the growth of the Allergy Relieving Eye Drops market in the US region. Moreover, North America is anticipated to be a highly attractive market for allergy-relieving eye drops, owing to the high cost of prescription drugs and a significant number of people in this region covered by medical insurance.

Allergy Relieving Eye Drops Market

Competitive Landscape

The majority of the allergy relieving eye drops are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market growth.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Incidence of Ocular Diseases

      2. 4.2.2 Increasing Research and Development in Eye Allergy Medication

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects from Eye Drops

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Drug Class

      1. 5.1.1 Antihistamines

      2. 5.1.2 Non-steroidal anti-Inflammatory Drugs

      3. 5.1.3 Vasoconstrictors

      4. 5.1.4 Others

    2. 5.2 By Type

      1. 5.2.1 Seasonal and Perennial Allergic Conjunctivitis

      2. 5.2.2 Vernal Keratoconjunctivitis

      3. 5.2.3 Atopic Keratoconjunctivitis

      4. 5.2.4 Giant Papillary Conjunctivitis

      5. 5.2.5 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc. (Allergan Plc)

      2. 6.1.2 Johnson & Johnson

      3. 6.1.3 Pfizer Inc.

      4. 6.1.4 F. Hoffmann-La Roche Ltd

      5. 6.1.5 Novartis AG

      6. 6.1.6 Bausch Health Companies Inc

      7. 6.1.7 Regeneron Pharmaceuticals

      8. 6.1.8 Santen Pharmaceutical Co

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Allergy Relieving Eye Drops Market market is studied from 2018 - 2026.

The Allergy Relieving Eye Drops Market is growing at a CAGR of 4.14% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Johnson & Johnson, Novartis AG, Bausch Health, Santen Pharmaceutical Co., Ltd., AbbVie Inc. are the major companies operating in Allergy Relieving Eye Drops Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!